Correlation Between Mereo BioPharma and Sanlam Global

Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Sanlam Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Sanlam Global into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mereo BioPharma Group and Sanlam Global Artificial, you can compare the effects of market volatilities on Mereo BioPharma and Sanlam Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Sanlam Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Sanlam Global.

Diversification Opportunities for Mereo BioPharma and Sanlam Global

-0.75

Correlation Coefficient

Mereo BioPharma  Sanlam Global

Pay attention - limited upside

The 3 months correlation between Mereo and Sanlam is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Sanlam Global Artificial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanlam Global Artificial and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Sanlam Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanlam Global Artificial has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Sanlam Global go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Sanlam Global

Assuming the 90 days trading horizon Mereo BioPharma Group is expected to under-perform the Sanlam Global. In addition to that, Mereo BioPharma is 4.52 times more volatile than Sanlam Global Artificial. It trades about -0.1 of its total potential returns per unit of risk. Sanlam Global Artificial is currently generating about -0.02 per unit of volatility. If you would invest  38,051  in Sanlam Global Artificial on September 22, 2024 and sell it today you would lose (192.00) from holding Sanlam Global Artificial or give up 0.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.65%
Values	Daily Returns

Mereo BioPharma Group  vs.  Sanlam Global Artificial

Mereo BioPharma Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Sanlam Global Artificial

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Sanlam Global Artificial are ranked lower than 17 (%) of all funds and portfolios of funds over the last 90 days. Even with relatively weak technical and fundamental indicators, Sanlam Global reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mereo BioPharma and Sanlam Global

The main advantage of trading using opposite Mereo BioPharma and Sanlam Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Sanlam Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanlam Global will offset losses from the drop in Sanlam Global's long position.

The idea behind Mereo BioPharma Group and Sanlam Global Artificial pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.